Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.850
-0.010-0.21%
Volume:95.91M
Turnover:469.08M
Market Cap:55.99B
PE:9.14
High:5.000
Open:4.850
Low:4.810
Close:4.860
Loading ...

PRESS DIGEST-British Business - Oct 8

Reuters
·
08 Oct 2024

Stock Track | CSPC Pharma Shares Surge on Billion-Dollar Licensing Deal with AstraZeneca

Stock Track
·
08 Oct 2024

Stock Track | CSPC Pharma Surges on $1.92 Billion Licensing Deal with AstraZeneca for Promising Lipid-Lowering Therapy

Stock Track
·
08 Oct 2024

CSPC Pharmaceutical Grants License to AstraZeneca for Manufacturing, Marketing of Lipoprotein Inhibitor

MT Newswires Live
·
07 Oct 2024

AstraZeneca Licenses Potential Cardiovascular Therapy for Up to $2 Billion

Dow Jones
·
07 Oct 2024

UPDATE 1-AstraZeneca signs $1.92 bln licencing deal with HK-listed CSPC

Reuters
·
07 Oct 2024

AstraZeneca to pay up to $2 billion to license cardiovascular drug

Dow Jones
·
07 Oct 2024

AstraZeneca in $1.9 bln licensing deal with HK-listed CSPC

Reuters
·
07 Oct 2024

Stock Track | CSPC Pharmaceutical Soars on $1.92 Billion Licensing Deal with AstraZeneca

Stock Track
·
07 Oct 2024

BRIEF-CSPC Pharmaceutical Says Exclusive License Agreement For Ys2302018 With Astrazeneca

Reuters
·
07 Oct 2024

BRIEF-Astrazeneca Enters License Agreement With CSPC For Lipid-Lowering Therapy

Reuters
·
07 Oct 2024

CSPC Pharmaceutical - Group Will Receive an Upfront Payment of US$100 Mln

THOMSON REUTERS
·
07 Oct 2024

CSPC Pharmaceutical - Also Eligible to Receive up to US$1,550 Mln in Potential Sales Milestone Payments

THOMSON REUTERS
·
07 Oct 2024

Voluntary Announcement - Exclusive License Agreement for YS2302018 With AstraZeneca

THOMSON REUTERS
·
07 Oct 2024

Stock Track | CSPC PHARMA Soars on Exclusive Licensing Deal for Promising Cancer Drug

Stock Track
·
01 Oct 2024

Hong Kong Stocks Surge as China's Property Sector Rescue Overshadows Weak PMI Data

MT Newswires Live
·
30 Sep 2024